Medtronic PLC header image

Medtronic PLC

MDT

Equity

ISIN IE00BTN1Y115 / Valor 25187155

New York Stock Exchange, Inc (2026-03-25)
USD 87.89+1.51%

Medtronic PLC
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Medtronic PLC is a global leader in healthcare technology, focusing on the development and innovation of medical solutions to address some of the world's most complex and challenging health conditions. With a commitment to improving lives, the company leverages data, artificial intelligence, and an in-depth understanding of the human body to create groundbreaking technologies. Medtronic's portfolio includes a wide range of products and therapies designed to alleviate pain, restore health, and extend life, impacting patients across various medical fields. The company's approach to innovation emphasizes less-invasive surgical techniques, the development of compact medical devices such as the smallest pacemaker, and the advancement of robotic-assisted surgery to enhance precision and predictability in medical procedures. Medtronic's mission is driven by a focus on compassionate care, aiming to transform two lives per second through technologies that integrate seamlessly into patients' lifestyles and improve clinical, economic, and societal outcomes worldwide.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-0.79%1Y
10.7%3Y
-24.6%5Y

Performance

20.8%1Y
20.3%3Y
21.5%5Y

Volatility

Market cap

112841 M

Market cap (USD)

Daily traded volume (Shares)

9,380,121

Daily traded volume (Shares)

1 day high/low

80.25 / 79.29

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Bristol-Myers Squibb Co
Bristol-Myers Squibb Co Bristol-Myers Squibb Co Valor: 914188
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.70%USD 58.94
CVS Health Corp
CVS Health Corp CVS Health Corp Valor: 548525
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.85%USD 72.18
SHL Telemedicine Ltd
SHL Telemedicine Ltd SHL Telemedicine Ltd Valor: 1128957
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.95%CHF 1.04
Amylyx Pharmaceuticals Inc
Amylyx Pharmaceuticals Inc Amylyx Pharmaceuticals Inc Valor: 115580129
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.24%USD 13.83
Staar Surgical Co
Staar Surgical Co Staar Surgical Co Valor: 972813
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.16%USD 19.19
Hutchmed (China) Limited
Hutchmed (China) Limited Hutchmed (China) Limited Valor: 30165904
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.21%USD 14.15
Guardant Health Inc
Guardant Health Inc Guardant Health Inc Valor: 43633454
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.58%USD 86.58
National Vision Holdings Inc
National Vision Holdings Inc National Vision Holdings Inc Valor: 38523646
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.04%USD 28.06
Progyny Inc
Progyny Inc Progyny Inc Valor: 50342281
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.66%USD 17.75
AbCellera Biologics Inc
AbCellera Biologics Inc AbCellera Biologics Inc Valor: 58489933
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.42%USD 3.39